Vivet participating to a panel at 2018 Biotech & Money congress

BACK

Jean-Philippe Combal, Vivet Therapeutics’ CEO, will be part of a panel (Anatomy of a Private Finance Raise – Feb. 6 at 11.30) and handling 1-on-1 meetings during 2018 Biotech and Money World Congress in London on February 5-6.

BACK